Filing metadata

Accession number
0001493152-24-024124
Form type
Form 4
Filer
Anebulo Pharmaceuticals, Inc.
CIK
CIK 1815974
Filed
Jun 17, 2024
Reporting period
Jun 13, 2024
Description
Insider transaction

Explore SEC Filings Hub